107 related articles for article (PubMed ID: 25543012)
1. Improved bone defect healing by a superagonistic GDF5 variant derived from a patient with multiple synostoses syndrome.
Degenkolbe E; Schwarz C; Ott CE; König J; Schmidt-Bleek K; Ellinghaus A; Schmidt T; Lienau J; Plöger F; Mundlos S; Duda GN; Willie BM; Seemann P
Bone; 2015 Apr; 73():111-9. PubMed ID: 25543012
[TBL] [Abstract][Full Text] [Related]
2. A GDF5 point mutation strikes twice--causing BDA1 and SYNS2.
Degenkolbe E; König J; Zimmer J; Walther M; Reißner C; Nickel J; Plöger F; Raspopovic J; Sharpe J; Dathe K; Hecht JT; Mundlos S; Doelken SC; Seemann P
PLoS Genet; 2013; 9(10):e1003846. PubMed ID: 24098149
[TBL] [Abstract][Full Text] [Related]
3. New insights into the molecular mechanism of multiple synostoses syndrome (SYNS): mutation within the GDF5 knuckle epitope causes noggin-resistance.
Schwaerzer GK; Hiepen C; Schrewe H; Nickel J; Ploeger F; Sebald W; Mueller T; Knaus P
J Bone Miner Res; 2012 Feb; 27(2):429-42. PubMed ID: 21976273
[TBL] [Abstract][Full Text] [Related]
4. Negative mutation screening of the NOG, BMPR1B, GDF5, and FGF9 genes indicates further genetic heterogeneity of the facioaudiosymphalangism syndrome.
van den Ende JJ; Borra V; Van Hul W
Clin Dysmorphol; 2013 Jan; 22(1):1-6. PubMed ID: 22968293
[TBL] [Abstract][Full Text] [Related]
5. A point mutation in Fgf9 impedes joint interzone formation leading to multiple synostoses syndrome.
Tang L; Wu X; Zhang H; Lu S; Wu M; Shen C; Chen X; Wang Y; Wang W; Shen Y; Gu M; Ding X; Jin X; Fei J; Wang Z
Hum Mol Genet; 2017 Apr; 26(7):1280-1293. PubMed ID: 28169396
[TBL] [Abstract][Full Text] [Related]
6. GDF5 is a second locus for multiple-synostosis syndrome.
Dawson K; Seeman P; Sebald E; King L; Edwards M; Williams J; Mundlos S; Krakow D
Am J Hum Genet; 2006 Apr; 78(4):708-12. PubMed ID: 16532400
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of two novel missense mutations in the GDF5 proregion that reduce protein activity and are associated with brachydactyly type C.
Stange K; Thieme T; Hertel K; Kuhfahl S; Janecke AR; Piza-Katzer H; Penttinen M; Hietala M; Dathe K; Mundlos S; Schwarz E; Seemann P
J Mol Biol; 2014 Sep; 426(19):3221-3231. PubMed ID: 25092592
[TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor 5 regulation in bone regeneration.
Jin L; Li X
Curr Pharm Des; 2013; 19(19):3364-73. PubMed ID: 23432680
[TBL] [Abstract][Full Text] [Related]
9. Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN.
Seemann P; Brehm A; König J; Reissner C; Stricker S; Kuss P; Haupt J; Renninger S; Nickel J; Sebald W; Groppe JC; Plöger F; Pohl J; Schmidt-von Kegler M; Walther M; Gassner I; Rusu C; Janecke AR; Dathe K; Mundlos S
PLoS Genet; 2009 Nov; 5(11):e1000747. PubMed ID: 19956691
[TBL] [Abstract][Full Text] [Related]
10. GDF5 coordinates bone and joint formation during digit development.
Storm EE; Kingsley DM
Dev Biol; 1999 May; 209(1):11-27. PubMed ID: 10208739
[TBL] [Abstract][Full Text] [Related]
11. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes.
Settle SH; Rountree RB; Sinha A; Thacker A; Higgins K; Kingsley DM
Dev Biol; 2003 Feb; 254(1):116-30. PubMed ID: 12606286
[TBL] [Abstract][Full Text] [Related]
12. Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2.
Seemann P; Schwappacher R; Kjaer KW; Krakow D; Lehmann K; Dawson K; Stricker S; Pohl J; Plöger F; Staub E; Nickel J; Sebald W; Knaus P; Mundlos S
J Clin Invest; 2005 Sep; 115(9):2373-81. PubMed ID: 16127465
[TBL] [Abstract][Full Text] [Related]
13. A missense
Li J; Liang X; Wang X; Yang P; Jian X; Fu L; Deng A; Liu C; Liu J
JOR Spine; 2024 Mar; 7(1):e1302. PubMed ID: 38222807
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction.
Zaidi SH; Huang Q; Momen A; Riazi A; Husain M
J Am Coll Cardiol; 2010 Jan; 55(2):135-43. PubMed ID: 20117381
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein signals are required for cartilage formation and differently regulate joint development during skeletogenesis.
Tsumaki N; Nakase T; Miyaji T; Kakiuchi M; Kimura T; Ochi T; Yoshikawa H
J Bone Miner Res; 2002 May; 17(5):898-906. PubMed ID: 12009021
[TBL] [Abstract][Full Text] [Related]
16. Effects of growth/differentiation factor 5 on the survival and morphology of embryonic rat midbrain dopaminergic neurones in vitro.
O'Keeffe GW; Dockery P; Sullivan AM
J Neurocytol; 2004 Sep; 33(5):479-88. PubMed ID: 15906156
[TBL] [Abstract][Full Text] [Related]
17. 6-Hydroxydopamine induces distinct alterations in GDF5 and GDNF mRNA expression in the rat nigrostriatal system in vivo.
Gavin AM; Walsh S; Wyatt S; O'Keeffe GW; Sullivan AM
Neurosci Lett; 2014 Feb; 561():176-81. PubMed ID: 24373993
[TBL] [Abstract][Full Text] [Related]
18. Trps1 plays a pivotal role downstream of Gdf5 signaling in promoting chondrogenesis and apoptosis of ATDC5 cells.
Itoh S; Kanno S; Gai Z; Suemoto H; Kawakatsu M; Tanishima H; Morimoto Y; Nishioka K; Hatamura I; Yoshida M; Muragaki Y
Genes Cells; 2008 Apr; 13(4):355-63. PubMed ID: 18363966
[TBL] [Abstract][Full Text] [Related]
19. Heads, Shoulders, Elbows, Knees, and Toes: Modular Gdf5 Enhancers Control Different Joints in the Vertebrate Skeleton.
Chen H; Capellini TD; Schoor M; Mortlock DP; Reddi AH; Kingsley DM
PLoS Genet; 2016 Nov; 12(11):e1006454. PubMed ID: 27902701
[TBL] [Abstract][Full Text] [Related]
20. Brachydactyly Type C patient with compound heterozygosity for p.Gly319Val and p.Ile358Thr variants in the GDF5 proregion: benign variants or mutations?
Stange K; Ott CE; Schmidt-von Kegler M; Gillesen-Kaesbach G; Mundlos S; Dathe K; Seemann P
J Hum Genet; 2015 Aug; 60(8):419-25. PubMed ID: 25994865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
